BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8946914)

  • 1. A dominant interfering Myb mutant causes apoptosis in T cells.
    Taylor D; Badiani P; Weston K
    Genes Dev; 1996 Nov; 10(21):2732-44. PubMed ID: 8946914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant interfering alleles define a role for c-Myb in T-cell development.
    Badiani P; Corbella P; Kioussis D; Marvel J; Weston K
    Genes Dev; 1994 Apr; 8(7):770-82. PubMed ID: 7926766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference of Myb transactivation activity by a conditional dominant negative protein: functional interference in a cytotoxic T-cell line results in G1 arrest.
    Lyon JJ; Watson RJ
    Gene; 1996 Dec; 182(1-2):123-8. PubMed ID: 8982077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of apoptosis in K562 cells by dominant negative c-myb.
    Yi HK; Nam SY; Kim JC; Kim JS; Lee DY; Hwang PH
    Exp Hematol; 2002 Oct; 30(10):1139-46. PubMed ID: 12384144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of c-myc regulation by c-Myb in different cell lineages.
    Cogswell JP; Cogswell PC; Kuehl WM; Cuddihy AM; Bender TM; Engelke U; Marcu KB; Ting JP
    Mol Cell Biol; 1993 May; 13(5):2858-69. PubMed ID: 8474446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2.
    Hogg A; Schirm S; Nakagoshi H; Bartley P; Ishii S; Bishop JM; Gonda TJ
    Oncogene; 1997 Dec; 15(24):2885-98. PubMed ID: 9416832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associated with B-Myb-dependent bcl-2 induction.
    Grassilli E; Salomoni P; Perrotti D; Franceschi C; Calabretta B
    Cancer Res; 1999 May; 59(10):2451-6. PubMed ID: 10344757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Myb function in fibroblasts.
    Bein K; Husain M; Ware JA; Mucenski ML; Rosenberg RD; Simons M
    J Cell Physiol; 1997 Dec; 173(3):319-26. PubMed ID: 9369944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Myb regulates the proliferation of immature thymocytes following beta-selection.
    Pearson R; Weston K
    EMBO J; 2000 Nov; 19(22):6112-20. PubMed ID: 11080157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Maf interacts with c-Myb to down-regulate Bcl-2 expression and increase apoptosis in peripheral CD4 cells.
    Peng S; Lalani S; Leavenworth JW; Ho IC; Pauza ME
    Eur J Immunol; 2007 Oct; 37(10):2868-80. PubMed ID: 17823980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A-myb rescues murine B-cell lymphomas from IgM-receptor-mediated apoptosis through c-myc transcriptional regulation.
    Arsura M; Hofmann CS; Golay J; Introna M; Sonenshein GE
    Blood; 2000 Aug; 96(3):1013-20. PubMed ID: 10910917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the Ets2 transcription factor in the proliferation, maturation, and survival of mouse thymocytes.
    Zaldumbide A; Carlotti F; Pognonec P; Boulukos KE
    J Immunol; 2002 Nov; 169(9):4873-81. PubMed ID: 12391198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen prevents sustained COLO-205 human colon cancer cell growth by inducing apoptosis, decreasing c-myb protein, and decreasing transcription of the anti-apoptotic protein bcl-2.
    Wilkins HR; Doucet K; Duke V; Morra A; Johnson N
    Tumour Biol; 2010 Jan; 31(1):16-22. PubMed ID: 20237898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Myb down-regulation is associated with human colon cell differentiation, apoptosis, and decreased Bcl-2 expression.
    Thompson MA; Rosenthal MA; Ellis SL; Friend AJ; Zorbas MI; Whitehead RH; Ramsay RG
    Cancer Res; 1998 Nov; 58(22):5168-75. PubMed ID: 9823328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The conserved DNA binding domain mediates similar regulatory interactions for A-Myb, B-Myb, and c-Myb transcription factors.
    Rushton JJ; Ness SA
    Blood Cells Mol Dis; 2001; 27(2):459-63. PubMed ID: 11259168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription regulation by murine B-myb is distinct from that by c-myb.
    Watson RJ; Robinson C; Lam EW
    Nucleic Acids Res; 1993 Jan; 21(2):267-72. PubMed ID: 8382794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptotic response to oncogenic stimuli: cooperative and antagonistic interactions between c-myb and the growth suppressor p53.
    Sala A; Casella I; Grasso L; Bellon T; Reed JC; Miyashita T; Peschle C
    Cancer Res; 1996 May; 56(9):1991-6. PubMed ID: 8616838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory domains of the A-Myb transcription factor and its interaction with the CBP/p300 adaptor molecules.
    Facchinetti V; Loffarelli L; Schreek S; Oelgeschläger M; Lüscher B; Introna M; Golay J
    Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):729-36. PubMed ID: 9210395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Maf induces monocytic differentiation and apoptosis in bipotent myeloid progenitors.
    Hegde SP; Zhao J; Ashmun RA; Shapiro LH
    Blood; 1999 Sep; 94(5):1578-89. PubMed ID: 10477683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
    Gudas JM; Klein RC; Oka M; Cowan KH
    Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.